Allowable Total Error Table References and Help

All Analytes (1004 records)

Sort Analyte Fluid Method Limit Source
11DE 11-Desoxycortisol S- 27.1% 5 BV
11DE 11-Deoxycortisol 30 nmol/L, 15% 7 RCPA

5HIAA 5HIAA 20 umol/day, 20% 7 RCPA

A1AC a1-Antichymotrypsin S- 16.8% 5 BV

AAT Alpha-1 antitrypsin +/- 3 SD 1 CLIA, 3

NYS, 6 AAB
AAT Alpha 1 Antitrypsin BNII 3 SD 4 CAP
AAT a1-Antitrypsin S- 9.2% 5 BV
AAT Alpha-1-Antitrypsin 3SD 6 AAB

ACE Angiotensin converting P- 17.9% 5 BV

enzyme

ACETAM Acetaminophen 25% 2 WLSH

ACETAM Acetaminophen +/- 15% 3 NYS
ACETAM Acetaminophen Abbott AxSym 3 SD 4 CAP

ACETAM Acetaminophen 2.5 mg/mL or 25% 6 AAB

ACETAM Acetaminophen 20% 8 CFX

ACETONE Acetone 25% 2 WLSH

ACID PHOS Acid phosphatase S- 10.3% 5 BV

ACID PHOS Acid phosphatase S- 13.2% 5 BV
tartrate resistent
ACID PHOS Acid Phos(Pros) 1.5 U/L & ug/L, 15% 7 RCPA

ACID PHOS Acid Phos(Total) 1.5 U/L & ug/L, 15% 7 RCPA
ACMV Anti-CMV Positive or Negative 3 NYS

ACRAT A/C Ratio 2.5 SD 2 WLSH

ACT Activated Clotting Time 2 SD 2 WLSH

(ACT)
ACT Activated Clotting 20% 6 AAB
Time

ACTH ACTH 2.0 pmol/L, 10% 7 RCPA

ADENOSINE Adenosine deaminase S- 16.7% 5 BV

ADREN Adrenaline 50 nmol/day, 33% 7 RCPA

AFP Alpha-fetoprotein +/- 3 SD 1 CLIA, 2

WLSH
AFP Alpha fetoprotein 3 SD 2 WLSH
(Prenatal screen)
AFP AFP (Amniotic Fluid) +/- 3 SD 3 NYS
AFP AFP (Maternal Sera) +/- 3 SD 3 NYS
AFP AFPTM +/- 3 SD 3 NYS
AFP AFP Centaur 3 SD 4 CAP
AFP AFP, Amniotic Fluid Centaur 3 SD 4 CAP
AFP AFP-Tumor (Chiron) Centaur 3 SD 4 CAP
AFP AFP 5 kIU/L, 20% 7 RCPA
AFP Alpha-fetoprotein 5 kIU/L, 20% 7 RCPA

AHIV Anti-Human Reaction or 1 CLIA

Immunodeficiency nonreactive
virus

ALA Urine ALA 5 umol/L, 25% 7 RCPA

ALB Albumin +/- 10% 1 CLIA, 2
WLSH, 3 NYS,
6 AAB
ALB Albumin AU640 10% 4 CAP
ALB Albumin-Blood BNII 20% 4 CAP
ALB Albumin-CSF BNII 20% 4 CAP
ALB Albumin S- 3.9% 5 BV
ALB Albumin, U- 46.1% 5 BV
concentration, first
morning
ALB Glycated albumin S- 7.2% 5 BV
ALB Albumin 2.0 g/L, 10% 7 RCPA
ALB Albumin-CSF CSF 0.10 g/L, 10% 7 RCPA
ALB Albumin-Urine U- 0.1 g/L, 10% 7 RCPA
ALB Albumin 10% 8 CFX

ALCOHOL Alcohol, blood +/- 25% 1 CLIA, 2

WLSH, 6 AAB

ALCOHOL Alcohol (Ethanol), Pos/Neg 2 WLSH

Urine
ALCOHOL Alcohol,blood +/- 10% 3 NYS
ALCOHOL Ethanol 20% or 2 SD 3 NYS
ALCOHOL Ethanol Abbott AxSym 80% consensus 4 CAP

ALCOHOL Ethanol, Blood HP GLC 25% 4 CAP

ALCOHOL Ethanol, Urine HP GLC 25% or 9 mg/dL 4 CAP
(greater)
ALCOHOL Alcohol, Serum 25% 6 AAB
ALCOHOL Alcohol 2.2 mmol/L, 10% 7 RCPA
ALCOHOL Ethanol 15% 8 CFX

ALD Aldosterone S- 36.7% 5 BV

ALD Aldosterone, U- 39.6% 5 BV
concentration
ALD Aldosterone 75.0 pmol/L, 15% 7 RCPA

ALKP Alkaline phosphatase +/- 30% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
ALKP Alk Phos AU640 30% 4 CAP
ALKP Alkaline phosphatase S- 11.7% 5 BV

ALKP Alkaline phosphatase, S- 14.5% 5 BV

bone isoform
ALKP Alkaline Phosphatase 30% 6 AAB

ALKP Alkaline Phosphatase 15 U/L, 15% 7 RCPA

ALKP Alkaline Phosphatase 30% 8 CFX

ALT Alanine +/- 20% 1 CLIA, 2

aminotransferase (ALT, WLSH, 3 NYS,
SGPT) 6 AAB
ALT ALT AU640 20% 4 CAP
ALT Alanine S- 32.1% 5 BV
aminotransferase
ALT Alanine 20% 6 AAB
Aminotransferase
ALT ALT 8 U/L, 15% 7 RCPA
ALT Alanine 35% 8 CFX
Aminotransferase

AMIKACIN Amikacin 25% 2 WLSH

AMIKACIN Amikacin 2.0 mg/L, 10% 7 RCPA
AMIKACIN Amikacin 15% 8 CFX

AMIOD Amiodarone 0.2 umol/L, 10% 7 RCPA

AMITRIP Amitriptyline 10 umol/L, 10% 7 RCPA

AMITRIP Amitriptyline 15% 8 CFX

AMM Ammonia 2.5 SD 2 WLSH

AMM Ammonia AU640 not evaluated 4 CAP
AMM Ammonia, output U- 29.6% 5 BV
AMM Ammonia, Serum 10 umol/L or 5% 6 AAB
AMM Ammonia 3 umol/L, 10% 7 RCPA

AMPHET Amphetamines Pos/Neg 2 WLSH

AMPHET Amphetamines 20% or 2 SD 3 NYS
AMPHET Amphetamines, Presence or 3 NYS
qualitative Absence
AMPHET Amphetamine Abbott AxSym 80% consensus 4 CAP
AMY Amylase +/- 30% 1 CLIA, 2
WLSH, 3 NYS,
6 AAB
AMY Amylase -urine U- 30% 2 WLSH
AMY Amylase AU640 30% 4 CAP
AMY Amylase, urine U- AU640 3 SD 4 CAP
AMY a-Amylase S- 15.7% 5 BV
AMY a-Amylase S- 17.7% 5 BV
(pancreatic)
AMY a-Amylase U- 103.7% 5 BV
concentration, random

AMY Amylase 15 U/L, 15% 7 RCPA

AMY Amylase 20% 8 CFX

ANA Antinuclear antibody Target value +/- 2 1 CLIA, 3

dilution or (pos. or NYS
neg.)

AND Androstendione S- 22.6% 5 BV

AND Androstenedione 2.0 nmol/L 7 RCPA

ANTIDEPRESS Tricyclic Pos/Neg 2 WLSH

Antidepressants
ANTIDEPRESS Tricyclic 20% or 2 SD 3 NYS
Antidepressants
ANTIDEPRESS Tricyclic 10 nmol/L, 10% 7 RCPA
Antidepressants
ANTIDEPRESS Tricyclic 15% 8 CFX
Antidepressants

ANTITHROM Antithrombin III P- 8.3% 5 BV

APOA1 Apolipoprotein A1 BNII 3 SD 4 CAP

APOA1 Apolipoprotein A1 S- 9.1% 5 BV
APOA1 Apolipoprotein A1 25 mg/dL or 30% 6 AAB
APOA1 Apolipoprotein A1 0.2 g/L, 10% 7 RCPA
APOA1 Apolipoprotein AI 10% 8 CFX

APOB Apolipoprotein b BNII 3 SD 4 CAP

APOB Apolipoprotein B100 BNII not evaluated 4 CAP
APOB Apolipoprotein B S- 11.6% 5 BV
APOB Apolipoprotein B 20 mg/dL or 25% 6 AAB
APOB Apolipoprotein B 0.2 g/L, 10% 7 RCPA
APOB Apolipoprotein B 12% 8 CFX

APTT Partial thromboplastin +/- 15% 1 CLIA, 2

time WLSH, 3 NYS,
6 AAB
APTT Activated partial P- 4.5% 5 BV
thromboplastine time
APTT Activated Partial 15% 6 AAB
Thrombo Time

ASO Antistreptolysin O Target value +/- 2 1 CLIA, 3

dilution or (pos. or NYS
neg.)
ASO Aso-Antistreptolysin BNII 2 SD 4 CAP

AST Aspartate +/- 20% 1 CLIA, 2

aminotransferase WLSH, 3 NYS,
(AST, SGOT) 6 AAB
AST AST AU640 20% 4 CAP
AST Aspartate S- 15.2% 5 BV
aminotransferase
AST Aspartate 20% 6 AAB
Aminotransferase
AST AST 8 U/L, 15% 7 RCPA
AST Aspartate 20% 8 CFX
Aminotransferase

BARB Barbiturates Pos/Neg 2 WLSH

BARB Barbituates 20% or 2 SD 3 NYS
BARB Barbiturate Abbott AxSym 80% consensus 4 CAP

BASO Basophile, count S- 38.5% 5 BV

BCAROT Beta Carotene 0.2 umol/L, 10% 7 RCPA

BENZ Benzodiazepines Pos/Neg 2 WLSH

BENZ Benzodiazepine 20% or 2 SD 3 NYS
BENZ Benzodiazepine Abbott AxSym 80% consensus 4 CAP

BENZOY Benzoylecgonine 20% or 2 SD 3 NYS

BILI Bilirubin, total +/- 0.4 mg/dL or +/- 1 CLIA, 2

20% (greater) WLSH, 3 NYS,
6 AAB
BILI Bilirubin,direct 0.4 mg/dL or 20% 2 WLSH
BILI Bilirubin,Neonatal 0.4 mg/dL or 20% 2 WLSH
BILI Bilirubin, Urine (qual) 80% Agreement 3 NYS
BILI Bilirubin, Direct AU640 20% or 0.4 mg/dL 4 CAP
(greater)
BILI Bilirubin, Total AU640 20% or 0.4 mg/dL 4 CAP
(greater)
BILI Bilirubin conjugated S- 44.5% 5 BV
BILI Bilirubin total S- 31.1% 5 BV
BILI Bilirubin, Total 0.4 mg/dL or 20% 6 AAB
BILI Direct Bilirubin 0.4 mg/dL or 20% 6 AAB
BILI Bilirubin - Total 5 umol/L, 10% 7 RCPA
BILI Bilirubin Conjugated 10 umol/L, 20% 7 RCPA
BILI Conjugated Bilirubin, 10 umol/L, 20% 7 RCPA
Neonatal
BILI Total Bilirubin, 15 umol/L, 10% 7 RCPA
Neonatal
BILI Bilirubin - Direct 50% 8 CFX
BILI Bilirubin - Neonatal 31% 8 CFX
BILI Bilirubin - Total 31% 8 CFX

BNP BNP 2.0 SD 2 WLSH

BNP BNP Centaur not evaluated 4 CAP
BNP BNP 5.0 pg/mL or 20% 6 AAB

BPb BPb: +/-4 g/dL (values 3 NYS

<40g/dL) or +/-10%
(values >40g/dL)

C3 Complement C3 +/- 3 SD 1 CLIA, 3

NYS, 6 AAB
C3 C3 Complement BNII 3 SD 4 CAP
C3 C3 complement S- 8.4% 5 BV
C4 Complement C4 +/- 3 SD 1 CLIA, 3
NYS, 6 AAB
C4 C4 Complement BNII 3 SD 4 CAP
C4 C4 complement S- 16% 5 BV

CA Calcium, total +/- 1.0 mg/dL 1 CLIA

CA Calcium AU640 1 mg/dL 4 CAP
CA Calcium S- 2.4% 5 BV
CA Calcium 1.0 mg/dL 6 AAB
CA Calcium U- 1.0 mg/dL 6 AAB
CA Calcium 0.10 mmol/L 7 RCPA
CA Calcium 8% 8 CFX

CA-ION Ionized Calcium 0.13 mmol/L 2 WLSH

CA-ION Calcium, Ionized Radiometer 3 SD 4 CAP
725
CA-ION Calcium, ionized U- 2.1% 5 BV
CA-ION Ionized Calcium 0.25 mmol/L 6 AAB
CA-ION Ionised Calcium 0.05 mmol/L 7 RCPA
CA-ION Calcium - Ionized 10% 8 CFX

CA-URI Calcium - urine U- 1 mg/dL 2 WLSH

CA-URI Calcium, urine U- AU640 31% 4 CAP
CA-URI Calcium, U- 34.1% 5 BV
concentration, 24h
CA-URI Calcium, output, 24h U- 31% 5 BV
CA-URI Calcium-Urine U- 0.20 mmol/L 7 RCPA

CA125 CA 125 2 SD 2 WLSH

CA125 CA125 +/- 3 SD 3 NYS
CA125 CA 125 antigen S- 38.2% 5 BV
CA125 CA-125 9 U/mL or 30% 6 AAB
CA125 CA125 20 kU/L, 20% 7 RCPA

CA15 CA 15-3 2 SD 2 WLSH

CA15 CA15-3 +/- 3 SD 3 NYS
CA15 CA 15.3 antigen S- 15.5% 5 BV
CA15 CA15-3 3 kU/L, 15% 7 RCPA
CA19 CA 19-9 2 SD 2 WLSH
CA19 CA19-9 +/- 3 SD 3 NYS
CA19 CA 19.9 antigen S- 44.3% 5 BV
CA19 CA19-9 3 kU/L, 15% 7 RCPA

CA27 CA27.29 +/- 3 SD 3 NYS

CA549 CA 549 antigen S- 16.2% 5 BV

CAFFEINE Caffeine 15% 8 CFX

CALCIT Calcitonin 2 ng/L, 10% 7 RCPA

CARBAM Carbamazepine +/- 25% 1 CLIA, 2

WLSH, 6 AAB

CARBAM Carbamazepine +/- 15% 3 NYS

CARBAM Carbamazepine Abbott AxSym 25% 4 CAP

CARBAM Carbamazepine, free TDX 3 SD 4 CAP

CARBAM Carbamazepine 2.0 umol/L, 10% 7 RCPA
CARBAM Carbamazepine 25% 8 CFX

CARBOXY Carboxyhemoglobin 3 SD 2 WLSH

CARBOXY Carboxyhemoglobin Radiometer 3 SD 4 CAP
725
CARBOXY Fractional 0.02 7 RCPA
Carboxyhemoglobin

CARCINOEMB Carcinoembryonic S- 21.8% 5 BV

antigen
CARCINOEMB Carcinoembryonic 1.2 ng/mL or 30% 6 AAB
Antigen

CAROT Total Carotenoids 0.4 umol/L, 10% 7 RCPA

CAROTENE b-Carotene S- 43% 5 BV

CATECOL Total catecolamines, U- 29.8% 5 BV
concentration, 24h

CD19 CD19+ 3 SD 2 WLSH

CD2 CD2+ 3 SD 2 WLSH

CD20 CD20+ 3 SD 2 WLSH

CD3 CD3+ 3 SD 2 WLSH

CD3 CD3+/CD4+ 3 SD 2 WLSH
CD3 CD3+/CD8+ 3 SD 2 WLSH
CD3 CD3-/CD16+56+ 3 SD 2 WLSH

CD4 CD4+ 3 SD 2 WLSH

CD45 Bright CD45-/CD14+ 3 SD 2 WLSH

CD5 CD5+ 3 SD 2 WLSH

CD8 CD8+ 3 SD 2 WLSH

CEA CEA 1.2 ng/mL or 30% 2 WLSH

CEA CEA +/- 3 SD 3 NYS
CEA CEA Abbott AxSym 3 SD 4 CAP

CEA CEA 2.0 ug/L, 20% 7 RCPA

CELLID Cell identification 90% or greater 1 CLIA, 3

consensus on NYS
identification

CERULOP Ceruloplasmin BNII 3 SD 4 CAP

CERULOP Ceruloplasmin S- 7.8% 5 BV
CHE Cholinesterase S- 8.9% 5 BV
CHE Cholinesterase, S- 7.4% 5 BV
catalitic activity

CHOL Cholesterol, total +/- 10% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
CHOL Cholesterol AU640 10% 4 CAP
CHOL Cholesterol S- 9% 5 BV
CHOL Cholesterol, Total 10% 6 AAB
CHOL Cholesterol 0.50 mmol/L, 5% 7 RCPA
CHOL Cholesterol - Total 9% 8 CFX

CHOL-H Cholesterol, high dens. +/- 30% 1 CLIA, 2

lipoprotein WLSH, 3 NYS,
6 AAB
CHOL-H HDL- Cholesterol AU640 30% 4 CAP
CHOL-H HDL 1 cholesterol S- 11.5% 5 BV
CHOL-H HDL 2 cholesterol S- 23.9% 5 BV
CHOL-H HDL 3 cholesterol S- 9.8% 5 BV
CHOL-H HDL cholesterol S- 11.1% 5 BV
CHOL-H HDL Cholesterol 30% 6 AAB
CHOL-H HDL Cholesterol 0.20 mmol/L, 10% 7 RCPA
CHOL-H Cholesterol - HDL 11% 8 CFX

CHOL-L Cholesterol,LDL 30% 2 WLSH

CHOL-L Cholesterol,LDL Non-graded analyte 3 NYS

CHOL-L LDL- Cholesterol AU640 20% 4 CAP

CHOL-L LDL Cholesterol S- 13.6% 5 BV
CHOL-L LDL Cholesterol 15 mg/dL or 20% 6 AAB
(Direct)
CHOL-L Cholesterol - LDL 15% 8 CFX

CI Chloride +/- 5% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
CI Chloride -urine U- 5% 2 WLSH
CI Chloride AU640 5% 4 CAP
CI Chloride Radiometer 5% 4 CAP
725
CI Chloride, urine U- AU640 3 SD 4 CAP
CI Chloride S- 1.5% 5 BV
CI Chloride 3.0 mmol/L 7 RCPA
CI Chloride-Sweat Sweat 2 mmol/L, 10% 7 RCPA
CI Chloride-Urine U- 2.0 mmol/L, 10% 7 RCPA
CI Chloride 5% 8 CFX

CK Creatine kinase +/- 30% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
CK CK, Total AU640 30% 4 CAP
CK Creatine kinase S- 30.3% 5 BV
CK Creatine Kinase 30% 6 AAB
CK Creatine Kinase 15 U/L, 15% 7 RCPA
CK Creatine Kinase 30% 8 CFX

CKMB Creatine kinase MB elevated 1 CLIA, 2

isoenzymes (present or absent) WLSH, 3 NYS,
or Target value +/- 3 6 AAB
SD Creatinine
CKMB CK-MB qualitative Pos/Neg 2 WLSH
CKMB Ck-MB Centaur 3 SD 4 CAP
CKMB Creatine kinase MB, S- 16.5% 5 BV
%
CKMB Creatine kinase MB, S- 24.1% 5 BV
activity
CKMB Creatine kinase MB, S- 31.2% 5 BV
mass
CKMB CK2 Isoenzyme 3SD 6 AAB
(CKMB)
CKMB CK-MB 6 U/L & ug/L, 15% 7 RCPA
CKMB CK-MB Activity 40% 8 CFX
CKMB CK-MB Mass 2 SD 8 CFX

CO2 Carbon Dioxide 5.0 mmol/L 2 WLSH

CO2 CO2 AU640 3 SD 4 CAP
CO2 Bicarbonate (Total 4 mEq/L or 20% 6 AAB
CO2)
CO2 Bicarbonate 2.0 mmol/L, 10% 7 RCPA
CO2 CO2 - Total 20% 8 CFX

COCAINE Cocaine Metab Pos/Neg 2 WLSH

COCAINE Cocaine-Metabolite Abbott AxSym 80% consensus 4 CAP
CONDUC Sweat Conductivity 2 mmol/L, 10% 7 RCPA

COPPER Copper P- 11.8% 5 BV

COPPER Copper S- 7.7% 5 BV

CORT Cortisol +/- 25% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
CORT Cortisol Centaur 25% 4 CAP
CORT Cortisol S- 29.8% 5 BV
CORT Cortisol 30 nmol/L, 15% 7 RCPA
CORT Cortisol 30% 8 CFX

CPEP C Peptide S- 11.7% 5 BV

CPEP C-Propeptide type I S- 11.6% 5 BV
procollagen
CPEP C Peptide 1.0 nmol/L, 10% 7 RCPA

CREA Creatinine +/- 0.3 mg/dL or +/- 1 CLIA, 2

15% (greater) WLSH, 3 NYS,
6 AAB
CREA Creatinine - 0.3 mg/dL or 17% 2 WLSH
quantitative, Urine
CREA Creatinine - semi 2 WLSH
quant, Urine
CREA Creatinine AU640 15% or 0.3 mg/dL 4 CAP
(greater)
CREA Creatinine, urine U- AU640 17% 4 CAP
CREA Creatinine S- 6.9% 5 BV
CREA Creatinine clearence Patient- 16% 5 BV
CREA Creatinine, U- 28.4% 5 BV
concentration
CREA Creatinine, output U- 15.4% 5 BV
CREA Deoxipyridinoline/creati U- 33% 5 BV
nine, morning sp
CREA Urine Creatinine U- 3 mg/dL or 15% 6 AAB
CREA Creatinine 0.01 mmol/L, 10% 7 RCPA
CREA Creatinine-Urine U- 0.5 mmol/L, 10% 7 RCPA
CREA Creatinine 25% 8 CFX

CRP hS-CRP 2.0 SD 2 WLSH

CRP CRP BNII 2 SD 4 CAP
CRP hs-CRP BNII not evaluated 4 CAP
CRP C-Reactive protein S- 68.3% 5 BV
CRP CRP 0.4 mg/dL or 3 SD% 6 AAB

CRP high sensitivity CRP 0.4 mg/L or 3 SD% 6 AAB

CRYPTOCOCCUS Cryptococcus Positive or Negative 3 NYS

neoformans Antigen or +/- 2 dilutions

CYCLO Cyclosporine TDX 3 SD 4 CAP

CYSTEIN Cystein P- 8.3% 5 BV

DDIM d-Dimer Pos/Neg 2 WLSH

(interpretation)
DDIM d-Dimer (quantitative) 2 SD 2 WLSH
DDIM d-Dimer (semi- Pos/Neg 2 WLSH
quantitative)
DDIM D-Dimer 30% 6 AAB

DEHYDROE Dehydroepiandrostero S- 22.2% 5 BV

ne sulfate

DEOXIP Deoxipyridinoline/creati U- 21.2% 5 BV

nine, 24h

DESIP Desipramine 15% 8 CFX

DHEA DHEA Sulfate 2.5 SD 2 WLSH

DHEA DHEA Sulphate 1.0 umol/L, 10% 7 RCPA
DHEA DHEA Sulphate 2 SD 8 CFX

DIFF Automated Differential 3SD 6 AAB

DIG Digoxin +/- 20% or 0.2 ng/mL 1 CLIA, 2
(greater) WLSH, 6 AAB

DIG Digoxin 15% or 0.2 ng/mL 3 NYS

DIG Digoxin Centaur 20% or 0.2 ng/mL 4 CAP
(greater)
DIG Digoxin 0.2 nmol/L, 10% 7 RCPA
DIG Digoxin 25% 8 CFX

DIPEP Dipeptidyl-peptidase P- 10.9% 5 BV

IV

DISOP Disopyramide 2.0 umol/L, 10% 7 RCPA

DISOP Disopyramide 15% 8 CFX

DMF DMF 0.45 mmol/L or 30% 6 AAB

DOP Dopamine 0.25 umol/day, 25% 7 RCPA

DPD DPD (Free)-Urine U- 15 nmol/L, 15% 7 RCPA

DPD DPD (Total)-Urine U- 15 nmol/L, 15% 7 RCPA

DRYWT Faecal Percent Dry 1, 10% 7 RCPA

Weight

ELASTASE Elastase-Pl P- 16.5% 5 BV

EOS Eosinophils, count B- 37.1% 5 BV

EP EP: +/-6 g/dL (values 3 NYS

<40g/dL) or +/-15%
(values >40g/dL)
ERYTH Erythrocyte count +/- 6% 1 CLIA, 2
WLSH, 3 NYS,
6 AAB
ERYTH Erythrocites, count B- 4.4% 5 BV
ERYTH Erythrocytes 6% 6 AAB

ESR Sedimentation Rate 2.5 SD 2 WLSH

[ESR]
ESR Erythrocyte 3SD 6 AAB
Sedimentation Rate
(ESR)
ESR Erythrocyte 3SD 6 AAB
Sedimentation Rate
(ESR) - Rapid

ESTRADIOL Estradiol 3 ng/mL or 30% 2 WLSH

ESTRADIOL Estradiol +/-25% or 30 pg/mL 3 NYS

ESTRADIOL Estradiol U- 27% 5 BV

ESTRADIOL Estradiol 3 pg/mL or 30% 6 AAB
ESTRADIOL Oestradiol 100 pmol/L, 20% 7 RCPA
ESTRADIOL Estradiol 2 SD 8 CFX

ESTRIOL Estriol 2.5 SD 2 WLSH

ESTRIOL Free Estriol +/-25% or 3.0 ng/mL 3 NYS

ESTRIOL Total Estriol +/-25% or 3.0 ng/mL 3 NYS

ESTRIOL Oestriol(total) 20 nmol/L, 10% 7 RCPA

ESTRIOL Oestriol(unconjugated) 5 nmol/L, 20% 7 RCPA

ESTRIOL Estriol - Total 2 SD 8 CFX

ESTRIOL Estriol - Unconjugated 2 SD 8 CFX

ESTROGEN Estrogen 2.5 SD 2 WLSH

ETHOSUX Ethosuximide +/- 20% 1 CLIA, 2

WLSH
ETHOSUX Ethosuximide +/- 15% 3 NYS
ETHOSUX Ethosuximide 3 umol/L, 10% 7 RCPA
ETHOSUX Ethosuximide 15% 8 CFX
FACTOR Factor VII coagulation P- 10.7% 5 BV

FACTOR Factor VIII coagulation P- 8.9% 5 BV

FACTOR Tumor Necrosis S- 48.4% 5 BV

Factor-a

FBG Fibrinogen +/- 20% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
FBG Fibrinogen P- 13.6% 5 BV

FENT Fentanyl 20% or 2 SD 3 NYS

FERRITIN Ferritin 4.5 ng/mL or 30% 2 WLSH

FERRITIN Ferritin Centaur 3 SD 4 CAP
FERRITIN Ferritine S- 17.3% 5 BV
FERRITIN Ferritin 4.5 ng/mL or 30% 6 AAB
FERRITIN Ferritin 6.0 ug/L, 15% 7 RCPA
FERRITIN Ferritin 19.3% 8 CFX

FK506 Tacrolimus (FK 506) IMX 3 SD 4 CAP

FOLATE Folate 0.9 ng/mL or 30% 2 WLSH

FOLATE RBC Folate 2.5 SD 2 WLSH
FOLATE Folate, Serum Centaur 3 SD 4 CAP
FOLATE Folate (B)Erthry- 26.7% 5 BV
FOLATE Folate S- 39% 5 BV
FOLATE Folate 0.9 ng/mL or 30% 6 AAB
FOLATE Folate 1.0 umol/day, 30% 7 RCPA
FOLATE Folate 2 SD 8 CFX

FOLIC Folic Acid +/- 30% or 2.0 3 NYS

ng/mL

FRUCT Fructosamine S- 4.5% 5 BV

FRUCT Fructosamine 30 umol/L, 10% 7 RCPA
FSH FSH 2 mIU/mL or 25% 2 WLSH
FSH FSH +/-25% 3 NYS
FSH FSH Centaur 3 SD 4 CAP
FSH Follicle stimulating S- 16.7% 5 BV
hormone
FSH Follicle-Stimulating 2 mIU/mL or 25% 6 AAB
Hormone
FSH FSH 4.0 IU/L, 20% 7 RCPA
FSH Follicle Stimulating 2 SD 8 CFX
Hormone

FT3 Free T3 3 SD 2 WLSH

FT3 Triiodothyronine, Free 1.5 pg/mL or 30% 6 AAB
(Free T3)
FT3 Free T3 3.0 pmol/L 7 RCPA
FT3 Triiodothyronine - Free 20% 8 CFX

FT4 Free thyroxine +/- 3 SD 1 CLIA, 2

WLSH, 3 NYS

FT4 T4, Free Centaur 3 SD 4 CAP

FT4 Free thyroxine (FT4) S- 9.9% 5 BV
FT4 Thyroxine, Free 3SD 6 AAB
FT4 Free T4 1.5 pmol/L, 15% 7 RCPA
(Endocrinology)
FT4 Free T4 (General 3 pmol/L, 15% 7 RCPA
Chemistry)
FT4 Thyroxine - Free 2 SD 8 CFX

GASTRIN Gastrin 25 pmol/L, 10% 7 RCPA

GENTA Gentamicin +/- 25% 1 CLIA, 2

WLSH, 6 AAB

GENTA Gentamicin +/- 15% 3 NYS

GENTA Gentamicin Abbott AxSym 25% 4 CAP

GENTA Gentamicin 0.5 mg/L, 10% 7 RCPA

GENTA Gentamicin 20% 8 CFX
GGT Gamma-glutamyl 20% 2 WLSH
transferase [GGT]
GGT Gamma +/- 30% 3 NYS
glutamyltransferase
GGT GGT AU640 3 SD 4 CAP
GGT g-glutamyltransferase S- 22.2% 5 BV

GGT gamma-Glutamyl- 10 IU/L or 20% 6 AAB

transferase
GGT GGT 8 U/L, 15% 7 RCPA
GGT Gamma- 30% 8 CFX
Glutamyltransferase

GH Growth Hormone 2 mU/L, 20% 7 RCPA

GLOB a1-Globulins S- 15.7% 5 BV

GLOB a2-Globulins S- 12.6% 5 BV
GLOB b-Globulins S- 11.7% 5 BV
GLOB b2-Microglobulin S- 9% 5 BV
GLOB g-Globulins S- 16.8% 5 BV
GLOB Globulins, total S- 8% 5 BV
GLOB Beta 2 microglobulin 0.06 mg/L or 30% 6 AAB
GLOB Beta-2 Microglobulin 0.2 mg/L, 10% 7 RCPA

GLU Glucose +/- 6 mg/dL or +/- 1 CLIA, 2

10% (greater) WLSH, 3 NYS,
6 AAB
GLU Glucose -urine U- 10% 2 WLSH
GLU Glucose, CSF 10% 2 WLSH
GLU Glucose, Whole Blood 20 mg/dL or 20% 2 WLSH

GLU Glucose, Urine (qual) 80% Agreement 3 NYS

GLU Glucose AU640 10% or 6 mg/dL 4 CAP
(greater)
GLU Glucose Radiometer 10% or 6 mg/dL 4 CAP
725 (greater)
GLU Glucose, Urine AU640 10% or 6 g/24 hs 4 CAP
(greater)
GLU Glucose S- 6.3% 5 BV
GLU Glucose-6-phosphate- (B)Erythr- 38.5% 5 BV
1-dehydrogenase
GLU Whole Blood Glucose 6 mg/dL or 10% 6 AAB

GLU Glucose 0.5 mmol/L, 10% 7 RCPA

GLU Glucose-Blood Gas BG 1.0 mmol/day, 10% 7 RCPA
GLU Glucose-CSF CSF 1.0 mmol/L, 10% 7 RCPA
GLU Glucose-Urine U- 1.0 mmol/L, 10% 7 RCPA
GLU Glucose (GLUC ) 0.3 mmol/L, 8.0% 8 CFX

GLYCOPRO a1-Acid Glycoprotein S- 16.2% 5 BV

H2O Water S- 3.3% 5 BV

HAPT Haptoglobin BNII not evaluated 4 CAP

HAPT Haptoglobin P, S- 27.3% 5 BV

HBA1C Hemoglobin A1c 1.0 or 25% 2 WLSH

HBA1C Hemoglobin,Total A1 1.0 or 25% 2 WLSH
HBA1C Total Glycated 1.2 or 20% 2 WLSH
Hemoglobin
HBA1C Hemoglobin A1 C S- 4.4% 5 BV
HBA1C Glycohemoglobin 1.00% or 25% 6 AAB
HBA1C Hemoglobin A1C 0.5, 5% 7 RCPA
HBA1C Glycated Hemoglobin 9% 8 CFX
A1c

HCG Human chorionic +/- 3 SD or (positive 1 CLIA, 2

gonadotropin or negative) WLSH, 3 NYS,
6 AAB
HCG hCG,qualitative Pos/Neg 2 WLSH
(serum)
HCG hCG (Maternal Sera) +/- 3 SD 3 NYS
HCG Qualitative hCG Positive or Negative 3 NYS

HCG Total Beta hCG +/- 3 SD 3 NYS

HCG hCG, Quant Centaur 3 SD 4 CAP
HCG Human Chorionic 3SD 6 AAB
Gonadotropin
HCG hCG-quantitative 3.0 IU/L, 15% 7 RCPA
HCG hCG-quantitative- U- 5 IU/L, 10% 7 RCPA
Urine
HCG hCG 32% 8 CFX

HCT Hematocrit +/- 6% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
HCT Hematocrit B- 4.1% 5 BV
HEPAT Hepatitis (HBsAg, anti- Reactive (positive) 1 CLIA
HBc, HBeAg) or nonreactive
(negative)
HEPAT Hepatitis (Anti-HBc Reactive (Positive) 3 NYS
HBsAg HBeAg Anti- or Nonreactive
HCV ) (Negative)

HETEROPHILE Heterophile Positive or Negative 3 NYS

or +/- 2 dilutions

HGB Hemoglobin +/- 7% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
HGB Hemoglobin,total 7% 2 WLSH
HGB Hemoglobin, Urine 80% Agreement 3 NYS
(qual)
HGB Hemoglobin B- 4.1% 5 BV
HGB Hemoglobin 3 g/L, 3% 7 RCPA
concentration

HIDROX 5'-Hidroxiindolacetate, U- 26.5% 5 BV

concentration, 2

HMMA HMMA 20 umol/day, 20% 7 RCPA

HOMOCY Homocysteine Non-graded analyte 3 NYS

HOMOCY Homocysteine IMX 3 SD 4 CAP

HOMOCY Homocysteine P- 17.7% 5 BV
HOMOCY Homocysteine 2.5 umol/L or 20% 6 AAB
HOMOCY Homocysteine 15% 8 CFX

HVA HVA 8 umol/day, 25% 7 RCPA

HYDROX 17- S- 30.2% 5 BV

Hydroxyprogesterone
HYDROX Galactosy S- 16.8% 5 BV
hydroxylisine
HYDROX Hydroxiproline/creatini S- 32.9% 5 BV
ne
HYDROX Hydroxiproline/minute, U- 43% 5 BV
night urine
HYDROX 17- 3 nmol/L, 20% 7 RCPA
Hydroxyprogesterone
HYDROX Hydroxyproline-Urine U- 10 umol/L, 10% 7 RCPA
HYDROX Beta-Hydroxybutyric 2 SD 8 CFX
Acid

IGA IgA +/- 3 SD 1 CLIA, 3

NYS, 6 AAB
IGA IgA, Blood BNII 3 SD 4 CAP
IGA Immunoglobulin A S- 13.5% 5 BV

IGB IgB +/- 3 SD 1 CLIA

IGE IgE +/- 3 SD 3 NYS

IGE IgE 3SD 6 AAB
IGE IgE Opt 3SD 6 AAB
IGE IgE 4.0 IU/L, 20% 7 RCPA

IGF IGF-1 3 nmol/L, 15% 7 RCPA

IGG IgG +/- 25% 1 CLIA, 3

NYS, 6 AAB
IGG IgG, Blood BNII 25% 4 CAP
IGG IgG-Blood BNII 3 SD 4 CAP
IGG IgG-CSF BNII 3 SD 4 CAP
IGG Immunoglobulin G S- 8% 5 BV
IGG Immunoglobin G-CSF CSF 0.1 g/L, 10% 7 RCPA

IGI Immunoglobulins l S- 8.6% 5 BV

chain

IGK Immunoglobulins K S- 8% 5 BV
chain
IGM IgM +/- 3 SD 1 CLIA, 3
NYS, 6 AAB
IGM IgM, Blood BNII 3 SD 4 CAP
IGM Immunoglobulin M S- 16.8% 5 BV

IMIP Imipramine 15% 8 CFX

IMMUNOF Immunofix Urine Sebia 90% consensus 4 CAP

Hydrasis LS
IMMUNOF Immunofixation Serum Sebia 90% consensus 4 CAP
Hydrasis LS

INR INR 2 SD 2 WLSH

INSULIN Insulin +/-25% or 3.0 3 NYS

uU/mL
INSULIN Insulin S- 32.9% 5 BV
INSULIN Insulin 5 mU/L, 25% 7 RCPA

INTERFERON Interferon receptor (B)Leuc- 17.7% 5 BV

INTERLEUKIN Interleukin-1B S- 36.5% 5 BV

INTERLEUKIN Interleukin-8 S- 29.6% 5 BV

IRON Iron, total +/- 20% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
IRON Iron AU640 20% 4 CAP
IRON Iron Saturation Calculated 3 SD 4 CAP
IRON Iron (B)Leuc- 30.7% 5 BV
IRON Iron 20% 6 AAB
IRON Iron 5 umol/L 7 RCPA
IRON Iron 31% 8 CFX

ISOPROP Isopropanol HP GLC not evaluated 4 CAP

KETONES Ketones, Urine (qual) 80% Agreement 3 NYS

LACTATE Lactate 0.2 mmol/L or 2SD 2 WLSH
LACTATE Lactate AU640 2 SD 4 CAP
LACTATE Lactate Radiometer 4 CAP
725
LACTATE Lactate B- 30.4% 5 BV
LACTATE Lactate 1.0 mmol/L, 10% 7 RCPA
LACTATE Lactate 1.0 mmol/day, 10% 7 RCPA

LACTATE Lactate-CSF CSF 0.1 mmol/L, 10% 7 RCPA

LACTATE Lactate 30% 8 CFX

LACTOF Lactoferrin P- 16.4% 5 BV

LACTOF Lactoferrin Opt 0.5 mg/mL or 20% 6 AAB

LDH Lactate +/- 20% 1 CLIA, 2

dehydrogenase (LDH) WLSH, 3 NYS,
6 AAB
LDH Lactate AU640 20% 4 CAP
Dehydrogenase
LDH Lactate S- 11.4% 5 BV
dehydrogenase (LDH)

LDH Lactate 20% 6 AAB

Dehydrogenase
LDH Lactate 30 U/L, 15% 7 RCPA
Dehydrogenase
LDH Lactate 20% 8 CFX
Dehydrogenase

LDH1 LDH isoenzymes LDH1/LDH2 (+ or -) 1 CLIA, 3

or Target value +/- NYS
30%
LDH1 Lactate S- 8.2% 5 BV
dehydrogenase 1
isoform (LDH1)

LDH2 Lactate S- 5.7% 5 BV

dehydrogenase 2
isoform (LDH2)
LDH3 Lactate S- 5.8% 5 BV
dehydrogenase 3
isoform (LDH3)
LDH3 LD Isoenzymes 3-5 3.00% or 30% 6 AAB

LDH4 Lactate S- 11% 5 BV

dehydrogenase 4
isoform (LDH4)

LDH5 Lactate S- 14.8% 5 BV

dehydrogenase 5
isoform (LDH5)

LEAD Blood lead +/- 10% or +/- 4 1 CLIA, 2

mcg/dL (greater) WLSH
LEAD Lead, Blood Spectra AA 10% or 4 ug/dL 4 CAP
(greater)

LH LH 2.5 SD 2 WLSH
LH LH +/-25% or 1.5 IU/L 3 NYS
LH LH Centaur 3 SD 4 CAP
LH Luteinizing hormone S- 19.8% 5 BV
LH Luteinizing Hormone 2 mIU/mL or 25% 6 AAB
LH LH 2.0 IU/L, 20% 7 RCPA
LH Luteinizing Hormone 2 SD 8 CFX

LIGNO Lignocaine 2.0 umol/L, 10% 7 RCPA

LIPASE Lipase 30% 2 WLSH

LIPASE Lipase AU640 30% 4 CAP
LIPASE Lipase S- 29.1% 5 BV
LIPASE Lipase 30% 6 AAB
LIPASE Lipase 40 U/L, 20% 7 RCPA
LIPASE Lipase 37% 8 CFX

LIPOP Lipoprotein (a) S- 28.8% 5 BV

LIPOP Lipoprotein (a) 10 mg/dL or 30% 6 AAB
LIPOP Lipoprotein (a) 2 SD 8 CFX
LITHIUM Lithium +/- 20% or 0.3 1 CLIA, 2
mmol/L WLSH, 6 AAB

LITHIUM Lithium +/- 15% or 0.3 3 NYS

mmol/L
LITHIUM Lithium AVL 9180 20% or 0.3 mEq/L 4 CAP
(greater)
LITHIUM Lithium 0.2 mmol/L 7 RCPA
LITHIUM Lithium 10% 8 CFX

LY Lymphocytes, count B- 16% 5 BV

MCH Mean corpuscular (B)Erythr- 2.7% 5 BV

hemoglobin (HCM)

MCHC Mean corpuscular (B)Erythr- 2.2% 5 BV

hemoglobin
concentratio

MCV MCV 3 SD 2 WLSH

MCV Mean corpuscular (B)Erythr- 2.3% 5 BV
volume (MCV)

METAN Metanephrine 0.5 umol/day, 33% 7 RCPA

METHADON Methadone Pos/Neg 2 WLSH

METHADON Methadone 20% or 2 SD 3 NYS

METHANOL Methanol HP GLC not evaluated 4 CAP

METHGB Methemoglobin 3 SD 2 WLSH

METHGB Methemoglobin Radiometer 2% 4 CAP
725
METHGB Fractional 1.0, 10% 7 RCPA
Methemoglobin

METHOT Methotrexate 0.1 umol/L, 10% 7 RCPA

METHOT Methotrexate 25% 8 CFX
METHQ Methqualone Pos/Neg 2 WLSH

MG Magnesium +/- 25% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
MG Magnesium - urine U- 25% 2 WLSH
MG Magnesium AU640 25% 4 CAP
MG Magnesium, urine U- AU640 25% 4 CAP
MG Magnesium (B)Erythr- 7.8% 5 BV
MG Magnesium (B)Leuc- 21.2% 5 BV
MG Magnesium S- 4.8% 5 BV
MG Magnesium, U- 52.2% 5 BV
concentration, 24h
MG Magnesium, ionized U- 2.9% 5 BV
MG Magnesium, output, U- 45% 5 BV
24h
MG Magnesium 3 mmol/L 7 RCPA
MG Magnesium (serum) U- 0.12 mmol/L 7 RCPA
MG Magnesium 0.1 mmol/L, 12% 8 CFX
MG Magnesium - Ionized 10% 8 CFX

MICROALB Microalbumin - 2.5 SD 2 WLSH

quantitative
MICROALB Microalbumin, urine U- AU640 3 SD 4 CAP
MICROALB Urine Microalbumin U- 10 mg/L or 25% 6 AAB

MICROGLOB a1-Microglobulin, U- 43.9% 5 BV

concentration, first m
MICROGLOB a2-Macroglobulin S- 7.6% 5 BV
MICROGLOB a2-Microglobulin U- 34.7% 5 BV
output, overnight

MONO Monocytes, count B- 27.9% 5 BV

MONONUC Infectious Target value +/- 2 1 CLIA

mononucleosis dilution or (pos. or
neg.)
MPV Mean platelet volume (B)Plat- 5.8% 5 BV
(MPV)

MRNA LDL receptor mRNA S- 24.1% 5 BV

MSAFP MSAFP Centaur 3 SD 4 CAP

MSHCG MShCG Centaur 3 SD 4 CAP

MUCIN Mucinous carcinoma- S- 18.5% 5 BV

associated antigen (M

MYOGLOB Myoglobin - qualitative Pos/Neg 2 WLSH

MYOGLOB Myoglobin - 2 SD 2 WLSH

quantitative
MYOGLOB Myoglobin S- 19.6% 5 BV
MYOGLOB Myoglobin 15 ng/mL or 30% 6 AAB
MYOGLOB Myoglobin 30% 8 CFX

NACET N-Acetyl U- 53.1% 5 BV

Glucosaminidase,
concentration,
NACET N-Acetyl U- 46.5% 5 BV
Glucosaminidase,
output

NEU Neutrophyles, count B- 22.4% 5 BV

NITROGEN Nitrogen, output U- 18.4% 5 BV

NORAD Noradrenaline 50 nmol/day, 10% 7 RCPA

NORMET Normetanephrine 1.0 umol/day, 33% 7 RCPA

NORTRIP Nortriptyline 10 nmol/L, 10% 7 RCPA
NORTRIP Nortriptyline 15% 8 CFX

NSE NSE 2.0 ug/L, 10% 7 RCPA

NUCLEO 5'Nucleotidase S- 26.8% 5 BV

OLIGOCL Oligoclonal Bands Sebia 90% consensus 4 CAP

Hydrasis LS

OPIATES Opiates Pos/Neg 2 WLSH

OPIATES Opiates 20% or 2 SD 3 NYS
OPIATES Opiate Abbott AxSym 80% consensus 4 CAP

OSMOL Osmolality,serum 3 SD 2 WLSH

OSMOL Osmolality,urine U- 3 SD 2 WLSH
OSMOL Osmolality Freezing 2 SD 4 CAP
point
OSMOL Osmolality, urine U- Freezing 3 SD 4 CAP
point
OSMOL Osmolality S- 1.5% 5 BV
OSMOL Osmolality U- 9. mOsm/kg or 10% 6 AAB

OSMOL Osmolality 8 mmol/kg 7 RCPA

OSMOL Osmolality-Urine U- 6 mmol/kg, 2% 7 RCPA
OSMOL Osmolality 3% 8 CFX

OST Osteocalcin S- 11.2% 5 BV

OXALATE Oxalate, concentration U- 48.2% 5 BV

OXALATE Oxalate, output U- 46.8% 5 BV

OXYHGB Oxyhemoglobin 3 SD 2 WLSH

OXYHGB Oxyhemoglobin Radiometer 4 CAP
725
OXYHGB Fractional 3, 4% 7 RCPA
Oxyhemoglobin
PAP PAP 2.5 SD 2 WLSH

PARACET Paracetamol 20 umol/L, 10% 7 RCPA

PCO2 Blood gas pCO2 +/- 5 mm Hg or +/- 1 CLIA, 2

8% (greater) WLSH, 3 NYS,
6 AAB
PCO2 pCO2 Radiometer 8% or 5 mm Hg 4 CAP
725 (greater)
PCO2 pCO2 B- 5.7% 5 BV
PCO2 pCO2 5.0 mm Hg or 8% 6 AAB
PCO2 pCO2 2.0 mm Hg, 8% 7 RCPA
PCO2 pCO2 5 kPa, 8% 8 CFX

PEROX Glutathione S- 11.7% 5 BV

peroxidase

PH Blood gas pH +/- 0.04 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
PH pH, Urine (qual) 80% Agreement 3 NYS
PH pH Radiometer 0.04 4 CAP
725
PH pH,Fluid Corning 445 0.04 4 CAP
pH meter
PH pH [H+] B- 3.9% 5 BV
PH pH 0.04 6 AAB
PH pH 0.04 7 RCPA
PH pH 0.04 8 CFX

PHENCY Phencyclidine Pos/Neg 2 WLSH

PHENCY Phencyclidine 20% or 2 SD 3 NYS
PHENCY Phencyclidine Abbott AxSym 80% consensus 4 CAP

PHENOBARB Phenobarbital +/- 20% 1 CLIA, 2

WLSH, 6 AAB

PHENOBARB Phenobarbital +/- 15% 3 NYS

PHENOBARB Phenobarbital Abbott AxSym 20% 4 CAP

PHENOBARB Phenobarbitone 3.0 umol/L, 10% 7 RCPA

PHENOBARB Phenobarbital 20% 8 CFX

PHENYTOIN Phenytoin +/- 25% 1 CLIA, 2

WLSH, 6 AAB

PHENYTOIN Free phenytoin +/- 20% 3 NYS

PHENYTOIN Phenytoin +/- 15% 3 NYS
PHENYTOIN Phenytoin Abbott AxSym 25% 4 CAP

PHENYTOIN Phenytoin, free TDX 3 SD 4 CAP

PHENYTOIN Phenytoin 3.0 umol/L, 10% 7 RCPA
PHENYTOIN Phenytoin 25% 8 CFX

PHOSLHOL Phospholipids S- 8.6% 5 BV

PHOSPATE Phosphate-Urine U- 2.5 mmol/L 7 RCPA

PHOSPHATE Phosphate S- 10.2% 5 BV

PHOSPHATE Phosphate tubular Patient- 3.3% 5 BV
reabsorption
PHOSPHATE Phosphate, U- 31.1% 5 BV
concentration
PHOSPHATE Phosphate, output U- 22.1% 5 BV
PHOSPHATE Phosphate 0.1 mmol/L, 10% 7 RCPA

PHOSPHORUS Phosphorus 0.5 mg/dL or 12% 2 WLSH

PHOSPHORUS Phosphorus -urine U- 0.5 mg/dL or 12% 2 WLSH
PHOSPHORUS Phosphorus +/- 0.45 mg/dL or 3 NYS
13%
PHOSPHORUS Phosphorus AU640 10.7% or 0.3 mg/dL 4 CAP
(greater)
PHOSPHORUS Phosphorus, urine U- AU640 23% 4 CAP
PHOSPHORUS Phosphorus 0.4 mg/dL or 15% 6 AAB
PHOSPHORUS Phosphorus U- 3. mg/dL or 15% 6 AAB
PHOSPHORUS Phosphorus 12% 8 CFX

PLT Platelet count +/- 25% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
PLT Platelet, count B- 13.4% 5 BV
PLT Platelets 25% 6 AAB

PO2 Blood gas p02 +/- 3 SD 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
PO2 pO2 Radiometer 3 SD 4 CAP
725
PO2 pO2 3SD 6 AAB
PO2 pO2 5 mm Hg, 5% 7 RCPA
PO2 pO2 2 SD 8 CFX

POLYLY Polylysine 45 mmol/L or 30% 6 AAB

PORPH Faecal Total Porphyrin 15 umol/kg, 15% 7 RCPA

PORPH Urine Porphobilinogen 5 umol/L, 20% 7 RCPA

(Quantitative)

PORPHYRIN Plasma Total 3 nmol/L, 15% 7 RCPA

Porphyrin
PORPHYRIN RBC Total Porphyrin 0.3 umol/L rc, 15% 7 RCPA
PORPHYRIN Urine Total Porphyrin 15 nmol/L, 15% 7 RCPA

POT Potassium +/- 0.5 mmol/L 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
POT Potassium - urine U- 2 SD 2 WLSH
POT Potassium Radiometer 0.5 mmol/L 4 CAP
725
POT Potassium, urine U- AU640 29% 4 CAP
POT Potassium` AU640 0.5 mmol/L 4 CAP
POT Potassium (B)Leuc- 16% 5 BV
POT Potassium S- 5.8% 5 BV
POT Potassium, U- 31.3% 5 BV
concentration
POT Potassium, output U- 28.4% 5 BV
POT Potassium 0.2 mmol/L 7 RCPA
POT Potassium-POCT POCT 2.0 mmol/L 7 RCPA
POT Potassium-Urine U- 2.0 mmol/L, 10% 7 RCPA
POT Potassium 6% 8 CFX
PREALB Pre-albumin 2.5 SD 2 WLSH
PREALB Prealbumin BNII 25% or 5 mg/dL 4 CAP
(greater)
PREALB Prealbumin S- 14.5% 5 BV

PREG Pregnancy, Serum pos/neg 6 AAB

PRIMIDONE Primidone +/- 25% 1 CLIA, 2

WLSH, 6 AAB

PRIMIDONE Primidone +/- 15% 3 NYS

PRIMIDONE Primidone 15% 8 CFX

PROC Procainamide (and +/- 25% 1 CLIA, 2

metabolite) WLSH, 6 AAB

PROC N-acetyl procainamide +/- 15% 3 NYS

PROC Procainamide +/- 15% 3 NYS

PROC N-acetylprocainamide Abbott AxSym 25% 4 CAP

PROC Napa Abbott AxSym 25% 4 CAP

PROC Procainamide Abbott AxSym 25% 4 CAP

PROC Procainamide 25% 6 AAB

PROC Procainamide, N- 25% 6 AAB
Acetyl (NAPA)
PROC N-acetylprocainamide 20% 8 CFX

PROC Procainamide 20% 8 CFX

PROCOLL C-Telopeptide type I S- 14.1% 5 BV

procollagen
PROCOLL Procollagen type 1 N- S- 10.5% 5 BV
terminal

PROGEST Progesterone 300 pg/mL or 30% 2 WLSH

PROGEST Progesterone +/-25% or 1.0 ng/mL 3 NYS

PROGEST Progesterone Centaur 3 SD 4 CAP

PROGEST Progesterone 0.3 ng/mL or 30% 6 AAB
PROGEST Progesterone 2 nmol/L, 25% 7 RCPA
PROGEST Progesterone 2 SD 8 CFX
PROLACTIN Prolactin 3.6 ng/mL or 30% 2 WLSH
PROLACTIN Prolactin +/-25% or 1.0 ug/L 3 NYS
PROLACTIN Prolactin Centaur 3 SD 4 CAP
PROLACTIN Prolactin (men) S- 21.1% 5 BV
PROLACTIN Prolactin 3.6 ng/mL or 30% 6 AAB
PROLACTIN Prolactin 20 mU/L, 20% 7 RCPA
PROLACTIN Prolactin 2 SD 8 CFX

PROLYL Prolyl endopeptidase P- 19.3% 5 BV

PROPOX Propoxyphene Pos/Neg 2 WLSH

PROPOX Propoxyphene 20% or 2 SD 3 NYS

PROTEIN Total protein +/- 10% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
PROTEIN Protein 10% 2 WLSH
PROTEIN Protein,total - urine U- 10% 2 WLSH
PROTEIN Protein, Urine (qual) 80% Agreement 3 NYS
PROTEIN CSF Protein AU640 2 SD 4 CAP
PROTEIN M-Protein Interpr. Sebia 90% consensus 4 CAP
Hydrasis LS
PROTEIN Protein El. Interpr, Sebia 90% consensus 4 CAP
Serum Hydrasis LS
PROTEIN Protein El. Interpr, Ur Sebia 90% consensus 4 CAP
24 Hydrasis LS
PROTEIN Protein El. Interpr, Sebia 90% consensus 4 CAP
Urine Hydrasis LS
PROTEIN Protein, Total AU640 10% 4 CAP
PROTEIN Total protein, urine U- AU640 44% 4 CAP
PROTEIN Glycated total protein S- 3.7% 5 BV

PROTEIN Protein C S- 18.7% 5 BV

PROTEIN Protein S P- 20.7% 5 BV
PROTEIN Protein, concentration U- 43.5% 5 BV

PROTEIN Protein, output U- 40% 5 BV

PROTEIN Protein, total S- 3.4% 5 BV
PROTEIN Total Protein 10% 6 AAB
PROTEIN Total Protein U- 1.0 mg/dL or 25% 6 AAB
PROTEIN Protein (Total) 5.0 g/L 7 RCPA
PROTEIN Total Protein-CSF CSF 0.1 g/L, 10% 7 RCPA
PROTEIN Total Protein-Urine U- 0.1 g/L, 10% 7 RCPA
PROTEIN Protein - Total 6% 8 CFX

PSA PSA 0.9 ng/mL or 30% 2 WLSH

PSA PSA - free 0.9 ng/mL or 30% 2 WLSH
PSA cPSA +/- 3 SD 3 NYS
PSA fPSA +/- 3 SD 3 NYS
PSA PSA +/- 3 SD 3 NYS
PSA PSA Abbott AxSym 3 SD 4 CAP

PSA Prostatic specific S- 30% 5 BV

antigen (PSA)
PSA Prostate-Specific 0.9 ng/mL or 30% 6 AAB
Antigen
PSA Free PSA 1.5 ug/L, 15% 7 RCPA
PSA Total PSA 1.5 ug/L, 15% 7 RCPA

PT Prothrombin time +/- 15% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
PT Prothrombin time P- 5.3% 5 BV
PT CoaguChek 15% 6 AAB
Prothrombin Time
PT Prothrombin Time (PT) 15% 6 AAB

PT Whole Blood 15% 6 AAB

Prothrombin Time

PTH PTH Centaur 3 SD 4 CAP

PTH PTH 2.5 pmol/L, 25% 7 RCPA

PYRIDIN Pyridinoline/creatinine, U- 12.1% 5 BV

morning spot

PYRUVATE Pyruvate B- 17.5% 5 BV

QUINIDINE Quinidine +/- 25% 1 CLIA, 2

WLSH, 6 AAB

QUINIDINE Quinidine +/- 15% 3 NYS

QUINIDINE Quinidine Abbott AxSym 25% 4 CAP
QUINIDINE Quinidine 2.0 umol/L, 10% 7 RCPA
QUINIDINE Quinidine 25% 8 CFX

RDW Red cell distribution B- 4.6% 5 BV

wide

RENIN Active Renin 1.0 uU/mL, 25% 7 RCPA

RENIN Plasma Renin Activity 1.0 ng/mL/hr, 25% 7 RCPA

RETIC Reticulocytes 3 SD 2 WLSH

RETIC Reticulocyte highly S- 24% 5 BV
fluorescent, count
RETIC Reticulocyte low S- 2.6% 5 BV
fluorescent, count
RETIC Reticulocyte medium S- 19.6% 5 BV
fluorescent, count
RETIC Reticulocyte, count S- 16.8% 5 BV
RETIC Reticulocyte Count 0.50% or 30% 6 AAB

RETINOL Retinol S- 18.1% 5 BV

RF Rheumatoid factor Target value +/- 2 1 CLIA

dilution or (pos. or
neg.)
RF Rheumatoid Factor Positive or Negative 3 NYS
or +/- 2 dilutions
RF Rheumatoid Factor BNII 2 SD 4 CAP
RF Rheumatoid factor S- 13.5% 5 BV

RUBELLA Rubella Target value +/- 2 1 CLIA

dilution or (pos. or
neg.)

SALICY Salicylate 25% 2 WLSH

SALICY Salicylate +/- 15% 3 NYS
SALICY Salicylates AU640 3 SD 4 CAP
SALICY Salicylates 25% 6 AAB
SALICY Salicylate 0.1 mmol/L, 10% 7 RCPA
SALICY Salicylates 20% 8 CFX
SCC SCC antigen S- 45.8% 5 BV

SELENIUM Selenium B- 14.5% 5 BV

SELENIUM Selenium P- 14.5% 5 BV

SEROTONIN Serotonin 0.3 umol/day, 30% 7 RCPA

SHBG Sex hormone binding S- 21.1% 5 BV

globulin (SHBG)
SHBG SHBG 5 nmol/L, 10% 7 RCPA

SICKLE Sickle Cell Screen Pos/Neg 2 WLSH

SODIUM Sodium +/- 4 mmol/L 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
SODIUM Sodium - urine U- 2 SD 2 WLSH
SODIUM Sodium AU640 4 mmol/L 4 CAP
SODIUM Sodium Radiometer 4 mmol/L 4 CAP
725
SODIUM Sodium, urine U- AU640 26% 4 CAP
SODIUM Sodium (B)Erythr- 4.6% 5 BV
SODIUM Sodium (B)Leuc- 57.7% 5 BV
SODIUM Sodium S- 0.9% 5 BV
SODIUM Sodium, concentration U- 28.8% 5 BV

SODIUM Sodium, output U- 32% 5 BV

SODIUM Sodium 3.0 mmol/L 7 RCPA
SODIUM Sodium-Sweat Sweat 2 mmol/L, 10% 7 RCPA
SODIUM Sodium-Urine U- 2.0 mmol/L, 10% 7 RCPA
SODIUM Sodium 4 mmol/L, 5% 8 CFX

SPECIFIC Specific gravity, Urine 80% Agreement 3 NYS

(qual)
SPECIFIC Specific Gravity U- 0.01 6 AAB

SPERM Sperm Count 3 million/mL or 25% 6 AAB

SPERM Sperm Morphology 5% normal or 20% 6 AAB
%
SPERM Sperm Viability 5% viable or 20%% 6 AAB

SUPEROX Superoxide dismutase (B)Erythr- 13.5% 5 BV

SUPEROX Superoxide dismutase S- 19.1% 5 BV

T-UP TUptake 3SD 6 AAB

T-UP T Uptake 7% 8 CFX

T3 Triiodothyronine +/- 3 SD 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
T3 T3, T3 Centaur 3 SD 4 CAP
T3 Triiodothyronine (T3) S- 11.4% 5 BV
T3 Triiodothyronine, Total 3SD 6 AAB
(T3)
T3 Total T3 0.3 nmol/L, 20% 7 RCPA
(Endocrinology)
T3 Total T3 (General 0.3 nmol/L, 15% 7 RCPA
Chemistry)
T3 Triiodothyronine - Total 20% 8 CFX

T3-UP T3 uptake +/- 3 SD by method 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
T3-UP T3 Uptake Centaur 3 SD 4 CAP
T3-UP T3-uptake S- 5.3% 5 BV

T4 Thyroxine +/- 20% or 1.0 1 CLIA, 2

mcg/dL (greater) WLSH, 3 NYS,
6 AAB
T4 T4, Total Centaur 20% or 1 ug/dL 4 CAP
(greater)
T4 Thyroxine (T4) S- 8.3% 5 BV
T4 Thyroxine, Total 1.0 g/dL or 20% 6 AAB
T4 Thyroxine 8 nmol/L, 15% 7 RCPA
T4 Total T4 8 nmol/L, 15% 7 RCPA
T4 Thyroxine - Total 8% 8 CFX
TBG Thyroxin binding S- 7.1% 5 BV
globulin (TBG)

TELOP N-Telopeptides-Urine U- 80 nmolBCE/L, 10% 7 RCPA

TESTOSERONE Testosterone 0.3 ng/mL or 30% 2 WLSH

TESTOSERONE Testosterone,free 0.3 ng/mL or 30% 2 WLSH
TESTOSERONE Testosterone +/-25% or 1.0 ng/dL 3 NYS

TESTOSERONE Testosterone Centaur 3 SD 4 CAP

TESTOSERONE Testosterone S- 14% 5 BV
TESTOSERONE Testosterone Saliva- 22.7% 5 BV
TESTOSERONE Testosterone 0.3 ng/mL or 30% 6 AAB
TESTOSERONE Testosterone 0.5 nmol/L, 20% 7 RCPA
TESTOSERONE Testosterone 2 SD 8 CFX

THC Cannabinoids Pos/Neg 2 WLSH

THC THC-cannabinoids 20% or 2 SD 3 NYS
THC Cannabinoid Abbott AxSym 80% consensus 4 CAP

THEOPHYL Theophylline +/- 25% 1 CLIA, 2

WLSH, 6 AAB

THEOPHYL Theophylline +/- 15% 3 NYS

THEOPHYL Theophylline Abbott AxSym 25% 4 CAP

THEOPHYL Theophylline 3.0 umol/L, 10% 7 RCPA

THEOPHYL Theophylline 25% 8 CFX

THYROGLOB Thyroglobulin S- 17.8% 5 BV

TIBC Iron binding capacity 20% 2 WLSH

TIBC Iron Binding Capacity AU640 20% 4 CAP
TIBC TIBC Centaur 20% 4 CAP
TIBC Total Iron Binding 25% 6 AAB
Capacity (TIBC)
TIBC TIBC 10.0 umol/L 7 RCPA
TIBC IBC - Total 25% 8 CFX
TOBRA Tobramycin +/- 25% 1 CLIA, 2
WLSH, 6 AAB

TOBRA Tobramycin +/- 15% 3 NYS

TOBRA Tobramycin Abbott AxSym 25% 4 CAP

TOBRA Tobramycin 0.5 mg/L, 10% 7 RCPA

TOBRA Tobramycin 25% 8 CFX

TOCOPHEROL a-Tocopherol S- 16.2% 5 BV

TPA Tissue polypeptide S- 36.1% 5 BV

antigen (TPA)

TPS Tissue polypeptide S- 58.3% 5 BV

specific antigen (TPS

TRANSF Transferrin 2.5 SD 2 WLSH

TRANSF Transferrin BNII 20% 4 CAP
TRANSF Carbohydrate deficient S- 15.7% 5 BV
transferrin
TRANSF Transferrin S- 3.8% 5 BV
TRANSF Transferrin 0.5 g/L 7 RCPA
TRANSF Transferrin 12% 8 CFX

TRIG Triglycerides +/- 25% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
TRIG Triglycerides AU640 25% 4 CAP
TRIG Triglyceride S- 27.9% 5 BV
TRIG Triglyceride 0.20 mmol/L, 10% 7 RCPA
TRIG Triglycerides 15% 8 CFX

TROPONIN Troponin I - qualitative Pos/Neg 2 WLSH

TROPONIN Troponin I - 2 SD 2 WLSH

quantitative
TROPONIN Troponin T - Pos/Neg 2 WLSH
qualitative
TROPONIN Troponin T - 2 SD 2 WLSH
quantitative
TROPONIN Troponin I Centaur not evaluated 4 CAP
TROPONIN Troponin I 0.9 ng/mL or 30% 6 AAB
TROPONIN Troponin T 0.1 ng/mL or 30% 6 AAB
TROPONIN Troponin I 0.2 ng/mL, 10% 7 RCPA
TROPONIN Troponin T 0.1 ng/mL, 10% 7 RCPA
TROPONIN Troponin I 2 SD 8 CFX
TROPONIN Troponin T 2 SD 8 CFX

TSH Thyroid stimulating +/- 3 SD 1 CLIA, 2

hormone WLSH, 3 NYS,
6 AAB
TSH TSH Centaur 3 SD 4 CAP
TSH Thyroid stimulating S- 24.6% 5 BV
hormone (TSH)
TSH Thyroid Stimulating 3SD 6 AAB
Hormone
TSH TSH 0.6 mU/L, 15% 7 RCPA
TSH Thyroid Stimulating 30% 8 CFX
Hormone

UE3 uE3 (Maternal Sera) +/- 3 SD 3 NYS

UIBC Unsaturated Iron 25% 6 AAB

Binding Capacity
(UIBC)
UIBC IBC - Unsaturated 2 SD 8 CFX

URATE Urate S- 11.9% 5 BV

URATE Urate, concentration, U- 28.7% 5 BV
24h
URATE Urate, output, 24h U- 21.1% 5 BV
URATE Urate 0.050 mmol/L 7 RCPA
URATE Urate-Urine U- 0.3 mmol/L 7 RCPA

UREA Urea Nitrogen +/- 2 mg/dL or +/- 1 CLIA

9% (greater)
UREA Urea Nitrogen - urine U- 2 mg/dL or 9% 2 WLSH
UREA Urea AU640 9% or 2 mg N/dL 4 CAP
(greater)
UREA Urea, urine U- AU640 21% 4 CAP
UREA Urea S- 15.7% 5 BV
UREA Urea, concentration, U- 27.3% 5 BV
24h
UREA Urea, output, 24h U- 22.1% 5 BV
UREA Urea 0.1 mmol/L, 10% 7 RCPA
UREA Urea-POCT POCT 1.0 mmol/L, 10% 7 RCPA
UREA Urea-Urine U- 20 mmol/L, 10% 7 RCPA
UREA Urea/Urea Nitrogen 16% 8 CFX

URICACID Uric acid +/- 17% 1 CLIA, 2

WLSH, 3 NYS,
6 AAB
URICACID Uric Acid - urine U- 17% 2 WLSH
URICACID Uric Acid AU640 17% 4 CAP
URICACID Uric acid, urine U- AU640 24% 4 CAP
URICACID Uric Acid 17% 6 AAB
URICACID Uric Acid U- 17% 6 AAB
URICACID Uric Acid 12% 8 CFX

VALPROIC Valproic acid +/- 25% 1 CLIA, 2

WLSH, 6 AAB

VALPROIC Valproic acid +/- 15% 3 NYS

VALPROIC Valproic Acid Abbott AxSym 25% 4 CAP

VALPROIC Valproic Acid, free TDX 3 SD 4 CAP

VALPROIC Valproic Acid 25% 6 AAB
VALPROIC Valproate 25 umol/L, 10% 7 RCPA
VALPROIC Valproic Acid 15% 8 CFX

VANCO Vancomycin 25% 2 WLSH

VANCO Vancomycin +/- 15% 3 NYS
VANCO Vancomycin Abbott AxSym 3 SD 4 CAP

VANCO Vancomycin 1.5 mg/mL or 25% 6 AAB

VANCO Vancomycin 2.0 mg/L, 10% 7 RCPA
VANCO Vancomycin 20% 8 CFX

VANILMANDEL Vanilmandelic Acid U- 31.3% 5 BV

concentration, 24h

VITA Vitamin A 0.3 umol/L, 10% 7 RCPA

VITB12 Vitamin B12 60 pg/mL or 30% 2 WLSH
VITB12 Vitamin B12 +/- 25% 3 NYS
VITB12 Vitamin B-12 Centaur 3 SD 4 CAP
VITB12 Vitamin B12 60 pg/mL or 30% 6 AAB
VITB12 Vitamin B12 20 pmol/L, 20% 7 RCPA

VITC Ascorbic Acid S- 29.9% 5 BV

VITD Vitamin D3 5 nmol/L, 15 7 RCPA

VITE Vitamin E 5.0 umol/L, 10% 7 RCPA

VONW Von Willebrand factor P- 7.4% 5 BV

WBC Leukocyte count +/- 15% 1 CLIA

WBC Leukocytes, count P- 14.6% 5 BV
WBC Leukocytes 15% 6 AAB

WCDIFF White cell Target +/- 3 SD 1 CLIA, 2

differentiation based on WLSH
percentage of
different types of
white cells

ZINC Zinc P- 11% 5 BV

ZINC Zinc S- 13.5% 5 BV

ZPP ZPP: +/-15% (mol/mol 3 NYS

heme)
EP 15 Presisi
Jumlah replikasi 3
Jumlah hari 5
Rep.1 Rep.2 Rep.3 Run Mean Run SD Varian
Hari 1 #DIV/0! #DIV/0! #DIV/0!
Hari 2 #DIV/0! #DIV/0! #DIV/0!
Hari 3 #DIV/0! #DIV/0! #DIV/0!
Hari 4 #DIV/0! #DIV/0! #DIV/0!
Hari 5 #DIV/0! #DIV/0! #DIV/0!

Mean Keseluruhan AV(E5;E9) #DIV/0!

Varian Within run (Vr) AV(G5;G9) #DIV/0!
SD Within run SQRT(E12) #DIV/0!
SD Between run SD(E5;E9) #DIV/0!
Varian Between run (Vb) E14^2 #DIV/0!
Ratio Vr/Vb E12/E15 #DIV/0!
Total Varian ((B2-1)/B2)*E12+E15 #DIV/0!
SD Laboratorium SQRT(E17) #DIV/0!
CV Laboratorium (E18/E11)*100 #DIV/0!

UJI REPLIKASI: (Short-Term Imprecision)

TEST :
METODA :
BAHAN :

Bahan Bahan Bahan

No Tanggal Waktu Analis
1 2 3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
TRUE VALUE (TV)
Rerata #DIV/0! #DIV/0! #DIV/0!
Standar Deviasi (SD) #DIV/0! #DIV/0! #DIV/0!
Coefficien of Varian (CV) #DIV/0! #DIV/0! #DIV/0!
Bias (d%) #DIV/0! #DIV/0! #DIV/0!
Total Error Allowable (TEa)
Short-Term Imprecision
#DIV/0! #DIV/0! #DIV/0!
ion) UJI REPLIKASI: (Long-Term Imprecision)
TEST :
METODA :
BAHAN :

Keterangan No Tanggal Waktu Analis Bahan 1

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
TRUE VALUE (TV)
Rerata #DIV/0!
Standar Deviasi (SD) #DIV/0!
Coefficien of Varian (CV) #DIV/0!
Bias (d%) #DIV/0!
Total Error Allowable (TEa)
long-Term Imprecision
#DIV/0!
g-Term Imprecision)

Bahan
Bahan 2 Keterangan
3
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!

#DIV/0! #DIV/0!
 DATA PERBANDINGAN METODA

No Test Result Comp. Result

1 256 262
2 303 294
3 256 262
4 303 294
5 127 121
6 345 348
7 42 41
8 154 154
9 398 388
10 213 204
11 99 101
12 375 375
13 168 162
14 240 239
15 256 262
16 303 294
17 29 25
18 345 348
19 93 92
20 436 431
21 29 25
22 345 348
23 42 41
24 154 154
25 398 388
26 93 92
27 99 101
28 375 375
29 168 162
30 240 239
31 256 262
32 303 294
33 29 25
34 345 348
35 93 92
36 240 239
37 72 69
38 312 308
39 29 25
40 345 348
EP15 Truness Protocol using Patient Samples

No Test Result (Y) Comp. Result(X) Yi - Xi (Yi - Xi - B)

1 0 0.000
2 0 0.000
3 0 0.000
4 0 0.000
5 0 0.000
6 0 0.000
7 0 0.000
8 0 0.000
9 0 0.000
10 0 0.000
11 0 0.000
12 0 0.000
13 0 0.000
14 0 0.000
15 0 0.000
16 0 0.000
17 0 0.000
18 0 0.000
19 0 0.000
20 0 0.000
21 0 0.000
22 0 0.000
23 0 0.000
24 0 0.000
25 0 0.000
26 0 0.000
27 0 0.000
28 0 0.000
29 0 0.000
30 0 0.000
31 0 0.000
32 0 0.000
33 0 0.000
34 0 0.000
35 0 0.000
36 0 0.000
37 0 0.000
38 0 0.000
39 0 0.000

40 0 0.000
SUM 0 0 0 0
#DIV/0! #DIV/0! 0.00 0.00
 Mean Y Mean X Bias SD Dif
AV(B3:B22) AV(C3:C22) AV(D3:D22) SD(E3:E22)
Confidence Limits t-Critical n upper lower
p=0,01 2.861 40 0.00 0.00
Verivication Limits Manuf. Claim upper lower
p=0,01 2 2.00 2.00

VERIFIKASI KLAIM PABRIKAN (2)

Dibandingkan Confidence Interval Laboratorium dengan Pabrikan

Upper Lower

Lab 0.00 0.00

Pabrikan 2.00 2.00

 O b s e r v e d In a c c u ra c y, % B ia s
TEa 0
% Bias #VALUE!
% CV #DIV/0!
TE #DIV/0!

0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0
0 0.2
ANALIS
UJI
METODA UJI (Y)
METODA PEMBANDING (X)
TEa

PERHITUNGAN REGRESI
SLOPE #VALUE!
INTERCEPT #VALUE!
R #VALUE!
R #VALUE!
PERSAMAAN GARIS Yc = #VALUE! + #VALUE! Xc

PERHITUNGAN PASANGAN DATA

JUMLAH PASANGAN 0
DERAJAT KEBEBASAN -1
MEAN Y MEAN X #DIV/0! #DIV/0!
BIAS (%) 0.00
SD dif 0.00
Nilai p t-test Nilai T - Test #VALUE! #VALUE!
Nilai p-Kritis Nilai T-Test Kritis 0.05 Err:502
#VALUE!

Jika Koefisien Korelasi (r) > 0,99 :

Persamaan Garis Regresi = Yc = #VALUE! + #VALUE! Xc
Xc = Medical Decision Concentration =
Maka Yc adalah #VALUE!

SE = Yc Xc
Jadi SE = #VALUE! SE #VALUE! %
TEcalc= SE + RE
SD saat uji impresisi = CV = #DIV/0! %
RE adalah 3x SD saat uji impresisi = 0.0 RE #DIV/0! %
Jadi TE = #VALUE! TE #VALUE! %
TEa = #DIV/0! TEa 0%
Kinerja Metoda diterima jika TE < TEa
Jadi : #VALUE!

Jika Koefisien Korelasi (r)<0,975 :

TEcalc = biasmeas + 3smeas

smeas = Standar Deviasi dari percobaan replikasi (uji Impresisi) = 0

biasmeas = Rerata perbedaan atau difference between averages dari perhitungan uji t =

Jadi TEcalc = 0
TEa = 0
Kinerja Metoda diterima jika TE < TEa
Jadi : 0

VERIFIKASI KLAIM PABRIKAN (1)

Patient Manufacturer
Comparisons Claim

N 40 40

Df 39 39
Bias 0.00 -
SD diff 0.00 -
t-value hit
#VALUE! Err:502
/krit
p-value hit
#VALUE! 0.05
/krit
TEa 0

Kriteria Penerimaan / penolakan berdasarkan hasil uji T

Jika T value hitung > T value kritis, Terdapat perbedaan akurasi antara metoda di
laboratorium dengan klaim pabrik
Jika T value hitung < T value kritis, Tidak terdapat perbedaan akurasi antara metoda di
laboratorium dengan klaim pabrik

Keputusan
#VALUE!

Kriteria penerimaan / penolakan berdasarkan perbandingan

dengan TEa
Jika Bias > TEa, Terdapat perbedaan akurasi antara metoda di laboratorium dengan klaim pabrik
Jika Bias < TEa, Tidak terdapat perbedaan akurasi antara metoda di laboratorium dengan klaim pabrik
Keputusan
0
 Medical Decision Chart
1

0.9

0.8

0.7
Unacceptabl e
0.6
Poor
0.5
Margi nal
0.4 Good
0.3 Excel ent
Word Cl ass
0.2
Operating Poi nt
0.1

0
0 0.2 0.4 0.6 0.8 1 1.2

Observed Imprecision, % CV
 Diference Plot
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39

Diagram Tebar
12
10
8
Metoda Uji

6
4
2
0
0 2 4 6 8 10 12
Metoda Pembanding
 0.00

T
etoda di

ara metoda di

ngan
 0

0
0
0
0
0
0
Unacceptabl e
0
Poor 0
Margi nal
0
Good
Excel ent
0
Word Cl ass 0
Operating Poi nt
0

0
0
0
0
0
0
0
0
0
0
0
 Perbedaan Met Uji dengan Mewt Pembanding (mg/dL)
Diference plo
No Test Result (Y) Comp. Result (X) Yi - Xi
1 0 40
2 0 30
3 0 20
4 0 10
5 0
0
6 0 0 2 4 6 8 10 12
-10
7 0
8 0 -20
9 0 -30
10 0 -40
11 0
12 0
13 0
f(x) =
14 0
15 0
R = 0
Diagram Tebar Me
16 0 12
17 0 10
18 0 8

Metode Uji
19 0
6
20 0
4
21 0
22 0 2
23 0 0
24 0 0
25 0
26 0
27 0 entry data
28 0
29 0 Intercept a
30 0 slope b
31 0 koefisien k r
32 0 Persamaan Garis
33 0 Xc = Medical Decision Concentra
34 0 Maka Yc =
35 0 SE = Yc Xc
36 0 Maka SE =
37 0 TEcalc= SE + RE
38 0 RE adalah 3x SD saat uji impresi
39 0 SD saat uji impresisi =
40 0 Jadi TE calc =
SUM 0 0 0
#DIV/0! #DIV/0! 0.00 Kinerja Metoda diterima jika TE
Mean Y Mean X Bias
AV(B3:B22) AV(C3:C22) AV(D3:D22)
Confidencet-Critical n upper
p=0,01 2.861 40 #REF!
VerivicatioManuf. Claim upper
p=0,01 2 #REF!

TEa 10 5 0

% Bias ### 0 10
12.0

Observed Inaccuracy, % Bias

% CV 2.81 3.3 0

TE ### 0 10
10.0

2.5 0 8.0
Quality Requirement 0 10
Allowable Total Error 10.0 2 0
6.0
Offset 0.0 0 10
Method Performance 1.7 0
4.0
Bias (% diff) #VALUE! 0 10
Imprecision (% CV) 2.8 0 0
0 10 2.0
Sigma Limits s
6 1.67
5 2.00 0.0
0.0 1.0
4 2.50
3
2
3.33
5.00
Ob
 Diference plot met uji dng met pembanding
40
30
20
10
0
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42
10
20
30
40
Nomor Data

Diagram Tebar Metode Uji dengan Metode Pembanding

2
0
8
6
4
2
0
0 100
Metode Pembanding

#VALUE!
#VALUE!
#VALUE!
Persamaan Garis Yc = a + bXc Yc = #VALUE! + ### Xc
Xc = Medical Decision Concentration = 200
#VALUE!
SE = Yc Xc
#VALUE! atau SE= #VALUE! %
calc
= SE + RE
RE adalah 3x SD saat uji impresisi = 16.83 RE = 8.415 %
5.61 CV = 2.805 %
Jadi TE calc = #VALUE! atau TE calc = #VALUE! %

Kinerja Metoda diterima jika TE < TEa

TEa = 20 atau 10 %
 Medical Decision Chart
12.0
Observed Inaccuracy, % Bias

10.0

8.0
6 Sigma
5 Sigma
6.0 4 Sigma
3 Sigma
4.0 2 Sigma
Operating Point

2.0

0.0
0.0 1.0 2.0 3.0 4.0 5.0 6.0

Observed Imprecision, % CV
 Jan Feb Mar Apr May
NO
Li LII Li LII Li LII Li LII Li
1 92 308 96 313 97 315 98 314 91
2 94 314 95 310 98 314 99 309 91
3 96 314 93 308 97 308 98 312 98
4 95 300 91 301 92 310 96 300
5 98 314 93 313 98 313 93
6 98 310 92 307 95 310 91
7 96 314 90 313 98 313 98 306 93
8 93 315 91 304 98 314 99 308 91
9 94 311 90 310 98 314 94 307
10 94 315 91 315 95 310 97 308 98
11 96 312 92 297 99 312 99 300 97
12 97 315 95 308 99 314 95 307 98
13 98 315 91 309 99 307 95 314 98
14 97 313 91 307 98 314 98
15 95 314 92 304 95 310 92 303 96
16 95 300 94 307 96 311 91 301 98
17 98 314 93 307 98 315 97 301 98
18 98 312 90 315 95 308 92 299 95
19 99 314 93 310 98 310 92 298 93
20 96 312 92 306 97 310 95 301
21 96 312 92 308 98 312 93 302 99
22 97 308 92 310 98 300 91 302 93
23 98 314 96 312 98 309 90 296 91
24 99 314 92 311 99 307 95 297 92
25 99 315 93 308 99 309 93 305 91
26 95 315 93 309 98 315 92
27 95 308 99 316 97 313 99 315 94
28 98 315 96 311 93 304 91
29 94 315 97 311 90 296 92
30 95 313 96 308 91 306 98
31 95 312 96 309

TV 94.80 300.20 94.80 300.20 94.80 300.20 94.80 300.20 94.80

RERATA 96.13 312.16 92.67 308.81 97.21 310.79 94.82 304.79 94.44
SD Pabrik 4.7 15 4.7 15 4.7 15 4.7 15 4.7
SD Januari 1.88 3.87
SD Jan Mar 2.65 4.01
CV 1.95 1.24
TEa
Bias
Sigma
May Jun Jul Aug Sep
LII Li LII Li LII Li LII Li LII
295 96 312 94 283 99 283 101 298
292 95 287 94 294
299 98 306 95 283 93 283
96 314 93 292 93 283 99 310
304 95 313 92 283 93 289 97 301
298 91 290 92 283
309 95 283 95 283 96 298
306 96 311 96 282 92 283 96 306
96 313 98 285 92 283 96 294
315 93 313 92 283 92 283 98 309
315 95 304 99 283 93 295 96 301
308 93 309 92 284 93 293 99 316
315 94 312 92 290 100 297
315 95 308 94 283 92 285 92 295
315 91 286 98 298 92 284 97 307
314 97 314 93 289 92 317
314 93 307 92 283 95 287 97 299
314 93 314 92 283 98 298 94 289
313 98 300 94 283 100 302 95 295
93 283 95 311 95 297 94 290
315 97 298 101 312 96 291
315 101 312 97 295 92 313 93 289
314 98 300 97 295 99 299 96 291
311 101 308 99 303 95 291
315 94 283 96 287 99 312 95 290
311 94 297 97 288 101 304 98 287
308 92 284 92 296 98 310 95 302
312 96 283 98 296 101 302 101 309
315 94 284 100 297 94 286
313 94 290 95 282 97 293
100 303

300.20 94.80 300.20 94.80 300.20 94.80 300.20 94.80 300.20

310.00 95.08 301.92 95.00 289.24 95.73 294.08 96.18 298.04
15 4.7 15 4.7 15 4.7 15 4.7 15
 HOMOGENITAS STABILITAS
NO
LEVEL I LEVEL II LEVEL I
NO a b a b 1 96
1 92 96 308 312 2 97
2 94 97 314 315 3 98
3 96 98 314 315 4 99
4 95 97 300 313 5 99
5 98 95 314 314 6 95
6 98 95 310 300 7 95
7 96 98 314 314 8 98
8 93 98 315 312 9 94
9 94 99 311 314 10 95
10 94 96 315 312 11 95
STABILITAS
LEVEL II
312
308
314
314
315
315
308
315
315
313
312